Skip to main content

Equity assessment of childhood immunisation at national and subnational levels in Myanmar: a benefit incidence analysis.

Publication ,  Journal Article
Win, ZM; Traill, T; Kyaw, ZL; Hnin, KT; Chit, PT; La, T; Deshpande, AS; Ogbuoji, O; Mao, W
Published in: BMJ global health
July 2022

Myanmar, a conflict-affected geographically and ethnically diverse lower middle-income country, was in the donor transition phase for health prior to the political unrest of the last year. This study analyses the distribution of benefit and utilisation of basic childhood vaccinations from the highly donor-dependent Expanded Program on Immunization for populations of different socioeconomic status (SES).We conducted a benefit incidence analysis with decomposition analysis to assess the equity of benefit. We used basic childhood immunisations-BCG, measles, diphtheria, pertussis and tetanus (DPT)/pentavalent, oral polio vaccine (OPV) and full vaccination-as measurements for healthcare use. Childhood immunisation data were collected from Myanmar Demographic and Health Survey. Cost of vaccines was obtained from UNICEF document and 'Immunization Delivery Cost Catalogue' and adjusted with regional cost variations. We reported Concentration Index (CI) and Achievement Index (AI) by SES, including wealth quintiles, maternal education and across geographic areas.Nationally, better-off households disproportionately used more services from the programme (CI-Wealth Index (CI-WI) for BCG, measles, DPT/pentavalent, OPV and full immunisation: 0.032, 0.051, 0.120, 0.091 and 0.137, respectively). Benefits had a pro-poor distribution for BCG but a less pro-rich distribution than utilisation for all other vaccines (CI-WI: -0.004, 0.019, 0.092, 0.045 and 0.106, respectively). Urban regions had a more pro-rich distribution of benefit than that in rural areas, where BCG and measles had a pro-poor distribution. Subnational analysis found significant heterogeneity: benefit was less equitably distributed, and AI was lower in conflict-affected states than in government-controlled areas. The major contributors to vaccine inequality were SES, antenatal care visits and paternal education.Donors, national government and regional government should better plan to maintain vaccine coverage while improving equity of vaccine services, especially for children of lower SES, mothers with less antenatal care visits and lower paternal education living in conflicted-affected remote regions.

Duke Scholars

Published In

BMJ global health

DOI

EISSN

2059-7908

ISSN

2059-7908

Publication Date

July 2022

Volume

7

Issue

7

Start / End Page

e007800

Related Subject Headings

  • Pregnancy
  • Myanmar
  • Measles
  • Incidence
  • Immunization
  • Humans
  • Female
  • Child
  • BCG Vaccine
  • 4206 Public health
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Win, Z. M., Traill, T., Kyaw, Z. L., Hnin, K. T., Chit, P. T., La, T., … Mao, W. (2022). Equity assessment of childhood immunisation at national and subnational levels in Myanmar: a benefit incidence analysis. BMJ Global Health, 7(7), e007800. https://doi.org/10.1136/bmjgh-2021-007800
Win, Zin Mar, Tom Traill, Zarni Lynn Kyaw, Khaing Thandar Hnin, Phway Thinzar Chit, Thazin La, Ashwini Sunil Deshpande, Osondu Ogbuoji, and Wenhui Mao. “Equity assessment of childhood immunisation at national and subnational levels in Myanmar: a benefit incidence analysis.BMJ Global Health 7, no. 7 (July 2022): e007800. https://doi.org/10.1136/bmjgh-2021-007800.
Win ZM, Traill T, Kyaw ZL, Hnin KT, Chit PT, La T, et al. Equity assessment of childhood immunisation at national and subnational levels in Myanmar: a benefit incidence analysis. BMJ global health. 2022 Jul;7(7):e007800.
Win, Zin Mar, et al. “Equity assessment of childhood immunisation at national and subnational levels in Myanmar: a benefit incidence analysis.BMJ Global Health, vol. 7, no. 7, July 2022, p. e007800. Epmc, doi:10.1136/bmjgh-2021-007800.
Win ZM, Traill T, Kyaw ZL, Hnin KT, Chit PT, La T, Deshpande AS, Ogbuoji O, Mao W. Equity assessment of childhood immunisation at national and subnational levels in Myanmar: a benefit incidence analysis. BMJ global health. 2022 Jul;7(7):e007800.

Published In

BMJ global health

DOI

EISSN

2059-7908

ISSN

2059-7908

Publication Date

July 2022

Volume

7

Issue

7

Start / End Page

e007800

Related Subject Headings

  • Pregnancy
  • Myanmar
  • Measles
  • Incidence
  • Immunization
  • Humans
  • Female
  • Child
  • BCG Vaccine
  • 4206 Public health